Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

The First Affiliated Hospital with Nanjing Medical University

9 clinical trials · 9 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by The First Affiliated Hospital with Nanjing Medical University

RECRUITINGPhase 2NCT05834764

Pyrotinib in Women With High-risk in Early Stage Breast Cancer

ExteNET study explored neratinib prolong anti-HER2 therapy after trastuzumab therapy found that it can improve disease-free survival in patients with lymph nodes positive; In...

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 1881 location
HER2-positive Breast Cancer
RECRUITINGNCT05950997

A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL

This is a single-arm, prospective study to assess the efficacy and safety of acalabrutinib combined with obinutuzumab in subjects with previously untreated chronic lymphocytic...

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 891 location
Chronic Lymphocytic Leukemia
RECRUITINGPhase 2NCT06762782

Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk...

This study is a prospective, randomized, controlled, open, phase II, multicenter clinical study, which aims to evaluate the efficacy and safety of lenvatinib for adjuvant...

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 2761 location
Hepatocellular Carcinoma (HCC)Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
RECRUITINGPhase 2NCT06696742

PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

This study intends to explore whether the combination of Clostridium butyricum can improve the current situation of poor anti-PD1 treatment effect in patients with bladder cancer.

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 601 location
Bladder (Urothelial, Transitional Cell) Cancer
RECRUITINGNCT04588168

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Purpose:To evaluate whether immediate multiparametric MRI evaluate the sensitivity of modified neoadjuvant chemotherapy early in patient with muscle invasive bladder cancer(MIBC)....

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 1001 location
Bladder Cancer
RECRUITINGPhase 2NCT06341595

Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

This trial is a prospective, single arm, single center, phase II clinical study aimed at subjects with advanced gastric cancer and para aortic lymph node metastasis, exploring the...

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 401 location
Gastric CancerGastric Cancer Metastatic to Regional Lymph Nodes
RECRUITINGNCT06588231

Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease

The benefits of cardiac rehabilitation have been supported by a large amount of evidence-based medicine. Cardiac rehabilitation can correct cardiovascular risk factors, reduce...

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 2001 location
Coronary Heart Disease
RECRUITINGNCT06463808

Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With...

This study is designed to evaluate the efficacy and safety of Recombinant Human Brain Natriuretic Peptide (rhBNP) in improving ventricular remodeling and cardiac function after...

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 1001 location
Ventricular RemodelingMyocardial Infarction, Anterior Wall
RECRUITINGEarly Phase 1NCT06613490

An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and...

A single-center, open-label dose-escalation design to evaluate the safety and efficacy of 3 infusions of anti CD19 CAR NK cells (KN5501), as well as the expansion and persistence...

Sponsor: The First Affiliated Hospital with Nanjing Medical UniversityEnrolling: 241 location
Antisynthetase SyndromeRheumatoid Arthritis